Genotype-phenotype complexity of the TR46/Y121F/T289A cyp51A azole resistance mechanism in Aspergillus fumigatus - PubMed (original) (raw)
Genotype-phenotype complexity of the TR46/Y121F/T289A cyp51A azole resistance mechanism in Aspergillus fumigatus
Eveline Snelders et al. Fungal Genet Biol. 2015 Sep.
Abstract
The Aspergillus fumigatus cyp51A gene TR46/Y121F/T289A mutation is a new emerging resistance mechanism with high-level voriconazole (VOR) resistance, and elevated MICs to all other medical azoles. This is highly worrisome as VOR is the primary drug for the treatment of many aspergillus diseases. The 46 base pair tandem repeat (TR46) is positioned at the same location of the cyp51A gene promoter region as has been described for other tandem repeats. The exact role of the TR46 in combination with the two amino acid changes (Y121F and T289A) in the CYP51A protein is unknown. In this study this azole resistance mechanism was investigated by recombinant analysis study combined with homology modelling. MICs of the TR46/Y121F/T289A recombinant corresponded to the MICs of the original clinical isolates containing the same mutations with high-level resistance to VOR. The TR46 or Y121F by itself has only a moderate effect on azole susceptibility. The combination of TR46/Y121F, however, appears to be highly resistant not only for VOR but also for itraconazole (ITZ). The genetic change of T289A in combination with TR46 or by itself has no significant effect on the phenotype but moderates the phenotype of the ITZ resistance only in the presence of Y121F. The striking resistant phenotype of the TR46/Y121F mutant is supported by the structural analysis of the CYP51A homology model. The A. fumigatus CYP51A Y121 residue forms an H-bond with the heme centre of the enzyme. Disruption of the H-bond by the Y121F substitution destabilizes the active centre of CYP51A which appears to be essential with respect to azole resistance. In CYP51A-azole complexes, residue T289 is in close proximity of the azole moiety of VOR. Replacement of the polar amino acid threonine by the more hydrophobic amino acid alanine might promote more stable drug-protein interactions and has thereby an impact on ITZ susceptibility, which is confirmed by the MICs of the genetic recombinants.
Keywords: Aspergillus fumigatus; Homology modelling; Multi-azole resistance; cyp51A.
Copyright © 2015 Elsevier Inc. All rights reserved.
Similar articles
- Quantitative Analysis of Single-Nucleotide Polymorphism for Rapid Detection of TR34/L98H- and TR46/Y121F/T289A-Positive Aspergillus fumigatus Isolates Obtained from Patients in Iran from 2010 to 2014.
Mohammadi F, Hashemi SJ, Zoll J, Melchers WJ, Rafati H, Dehghan P, Rezaie S, Tolooe A, Tamadon Y, van der Lee HA, Verweij PE, Seyedmousavi S. Mohammadi F, et al. Antimicrob Agents Chemother. 2015 Nov 2;60(1):387-92. doi: 10.1128/AAC.02326-15. Print 2016 Jan. Antimicrob Agents Chemother. 2015. PMID: 26525787 Free PMC article. - Azole, polyene and echinocandin MIC distributions for wild-type, TR34/L98H and TR46/Y121F/T289A Aspergillus fumigatus isolates in the Netherlands.
van Ingen J, van der Lee HA, Rijs TA, Zoll J, Leenstra T, Melchers WJ, Verweij PE. van Ingen J, et al. J Antimicrob Chemother. 2015 Jan;70(1):178-81. doi: 10.1093/jac/dku364. Epub 2014 Oct 9. J Antimicrob Chemother. 2015. PMID: 25301884 - First azole-resistant Aspergillus fumigatus isolates with the environmental TR46 /Y121F/T289A mutation in Iran.
Ahangarkani F, Puts Y, Nabili M, Khodavaisy S, Moazeni M, Salehi Z, Laal Kargar M, Badali H, Meis JF. Ahangarkani F, et al. Mycoses. 2020 May;63(5):430-436. doi: 10.1111/myc.13064. Epub 2020 Mar 13. Mycoses. 2020. PMID: 32056319 Free PMC article. - Exploring azole antifungal drug resistance in Aspergillus fumigatus with special reference to resistance mechanisms.
Chowdhary A, Sharma C, Hagen F, Meis JF. Chowdhary A, et al. Future Microbiol. 2014;9(5):697-711. doi: 10.2217/fmb.14.27. Future Microbiol. 2014. PMID: 24957095 Review. - [Azole resistance with environmental origin: What alternatives for the future?].
Rocchi S, Reboux G, Millon L. Rocchi S, et al. J Mycol Med. 2015 Dec;25(4):249-56. doi: 10.1016/j.mycmed.2015.10.008. Epub 2015 Nov 27. J Mycol Med. 2015. PMID: 26631951 Review. French.
Cited by
- Nonrandom Distribution of Azole Resistance across the Global Population of Aspergillus fumigatus.
Sewell TR, Zhu J, Rhodes J, Hagen F, Meis JF, Fisher MC, Jombart T. Sewell TR, et al. mBio. 2019 May 21;10(3):e00392-19. doi: 10.1128/mBio.00392-19. mBio. 2019. PMID: 31113894 Free PMC article. - Molecular Detection of Aspergillus: Application of a Real-Time PCR Multiplex Assay in Tissue Samples.
Sabino R, Simões H, Veríssimo C. Sabino R, et al. J Fungi (Basel). 2020 Jan 10;6(1):11. doi: 10.3390/jof6010011. J Fungi (Basel). 2020. PMID: 31936735 Free PMC article. - Sterol 14α-Demethylase Ligand-Binding Pocket-Mediated Acquired and Intrinsic Azole Resistance in Fungal Pathogens.
Rosam K, Monk BC, Lackner M. Rosam K, et al. J Fungi (Basel). 2020 Dec 22;7(1):1. doi: 10.3390/jof7010001. J Fungi (Basel). 2020. PMID: 33374996 Free PMC article. Review. - Understanding the clinical and environmental drivers of antifungal resistance in the One Health context.
Williams CC, Gregory JB, Usher J. Williams CC, et al. Microbiology (Reading). 2024 Oct;170(10):001512. doi: 10.1099/mic.0.001512. Microbiology (Reading). 2024. PMID: 39475703 Free PMC article. Review. - Mechanisms of triazole resistance in Aspergillus fumigatus.
Nywening AV, Rybak JM, Rogers PD, Fortwendel JR. Nywening AV, et al. Environ Microbiol. 2020 Dec;22(12):4934-4952. doi: 10.1111/1462-2920.15274. Epub 2020 Oct 21. Environ Microbiol. 2020. PMID: 33047482 Free PMC article. Review.